Health Care

Explore how Novo Nordisk’s AI partnership, coramitug breakthrough, and buy‑back plan could reshape its growth, diversify its pipeline, and impact investors.

CVS Health denies a partnership with Planned Parenthood, clarifying it only sells abortion medication in stores—not a strategic alliance.

Explore how Cigna’s global, mobility‑based coverage and cutting‑edge telehealth investment give expatriates seamless cross‑border care, boost patient outcomes, and strengthen health systems for 2026 and beyond.

FDA approves weekly self‑injection of Saphnelo (anifrolumab) for SLE, offering the same proven safety and efficacy of the IV drug with greater convenience for patients.

Novartis eyes 5‑6% revenue growth and a €700‑€900 million NPV for Rhapsido, its first oral CSU therapy, amid strong oncology profits and strategic M&A prospects.

Medtronic’s Sphere‑9 catheter earns FDA breakthrough status, slashing time‑to‑market, boosting revenue by up to $80 M annually, and setting the stage for a 15 % market share growth in a $3.8 B cardiovascular device industry.

Japanese equity gains spotlight tech and robotics, revealing how healthcare can adopt AI and automation for cost‑efficient, high‑quality care.

McKesson’s Q4 earnings reveal rising specialty‑drug revenues, supply‑chain resilience, and a bright outlook—insights that shape healthcare distribution and investor sentiment.

Discover how Astellas Pharma’s 2023 earnings surge, 11 % revenue growth and R&D focus signal strong future momentum despite market dips.

Discover how Daiichi Sankyo’s latest earnings forecast signals rising profits, expanding revenue, and strong pharma growth ahead of its April 2026 financial release.